Skip to main
TRIL
TRIL logo

Trillium Therapeutics (TRIL)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Trillium Therapeutics (TRIL) Stock

About Trillium Therapeutics (TRIL)

Trillium Therapeutics Inc. operates as a biopharmaceutical research and development company. It focuses on the immune system and its regulation. The company specializes in the discovery and development of protein therapeutics, such as monoclonal antibodies, secreted proteins, and peptides. It involves in therapeutic areas, including autoimmune disease, cancer, necrotizing enterocolitis, and transp...read more
Market cap$1.64B
Today's volume
Revenue (TTM)
Avg. daily volume3.25M
EBITDA (TTM)
Open
Price / earnings ratio74.87x
Today's range
Debt / equity
52 week range$5.8 - $20.96
5 year debt / equity-12.28x
Beta (LTM)1.16x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsNov 12, 2021
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 08, 2025, the market cap for TRIL stock is $1.64B

The current P/E ratio for TRIL stock is 74.87

The 52-week high for TRIL stock is $20.96. The current TRIL stock price $undefined is 100.00% below its 52-week high

The 52-week low for TRIL stock is $5.80. The current TRIL stock price $undefined has increased 100.00% from its 52-week low

No, the TRIL stock does not pay dividends to its shareholders

How to buy TRIL stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in TRIL stock

    Navigate to the Explore page. Then, type TRIL into the search bar. When you see TRIL stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased TRIL stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Trillium Therapeutics Stock Earnings

The value each TRIL share was expected to gain vs. the value that each TRIL share actually gained.

Trillium Therapeutics (TRIL) reported Q3 2021 earnings per share (EPS) of -$0.18, beating estimates of -$0.20 by 10.00%. In the same quarter last year, Trillium Therapeutics's earnings per share (EPS) was -$0.55. Trillium Therapeutics is expected to release next earnings on 11/12/2021, with an earnings per share (EPS) estimate of $0.

Buy Trillium Therapeutics (TRIL) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.